Minntech investigating Biocor oxygenator blood pressure drops; firm advises customers to suspend use.
This article was originally published in The Gray Sheet
Executive SummaryMINNTECH INVESTIGATION INTO BIOCOR OXYGENATOR BLOOD PRESSURE DROPS should shed light on the cause of the problem within three to four weeks, the firm states. Minntech sent a letter to its international distributors for the device on June 27 asking them to tell customers to stop using the oxygenator due to "reports of unexplained high pressure drops" during cardiopulmonary bypass procedures. The company is drafting another letter to perfusionists that it expects to send early in the week of July 1.
You may also be interested in...
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.